Sugi Predict

Sugi Predict / Compounds / SCHEMBL17889798

SCHEMBL17889798

SCHEMBL17889798

CC(=O)NC1[C@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O[C@H]3[C@H](O)[C@@H](CO[C@]4(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O[C@@H](O[C@H]4[C@@H](O)[C@@H](CO)O[C@@H](OCCCCCN)[C@@H]4O)[C@@H]3NC(C)=O)O[C@@H]2CO)O[C@H](CO)[C@H](O)[C@@H]1O

nearest known ligand 0.74

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SIGLEC7 Q9Y286 6/20 0.74
▸ MAG P20916 9/20 0.62
▸ SELL P14151 1/20 0.51
▸ SELP P16109 1/20 0.51
▸ SELE P16581 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16381410 0.96 SIGLEC7 (0.72) SIGLEC7MAGSELLSELPSELE
SCHEMBL17897302 0.96 SIGLEC7 (0.72) SIGLEC7MAGSELLSELPSELE
SCHEMBL17889802 0.96 SIGLEC7 (0.72) SIGLEC7MAGSELLSELPSELE
SCHEMBL16381196 0.96 SIGLEC7 (0.72) SIGLEC7MAGSELLSELPSELE
SCHEMBL17897337 0.96 SIGLEC7 (0.72) SIGLEC7MAGSELLSELPSELE
SCHEMBL17889797 0.96 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL21043890 0.96 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL21043895 0.96 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL21043889 0.96 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE
SCHEMBL16381198 0.96 SIGLEC7 (0.69) SIGLEC7MAGSELLSELPSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013365-B1 RM2 ANTIGENS AND USE THEREOF ACADEMIA SINICA (TW) 2019-06-05 — — EP disclosed
US-10086054-B2 RM2 antigens and use thereof ACADEMIA SINICA (TW) 2018-10-02 — — US disclosed
US-20160193310-A1 RM2 ANTIGENS AND USE THEREOF ACADEMIA SINICA 2016-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160193310-A1 RM2 ANTIGENS AND USE THEREOF LGALS2, MAN2B2, GALNT2 SIGLEC7 6/4885MAG 74/4885SELL 683/4885
US-10086054-B2 RM2 antigens and use thereof MAN2B2, LGALS2, GALNT2 SIGLEC7 6/4885MAG 72/4885SELL 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback